Sprissler, Ryan
Bina, Robert
Kasoff, Willard
Witte, Marlys H.
Bernas, Michael
Walter, Christina
Labiner, David M.
Lau, Branden
Hammer, Michael F.
Weinand, Martin E.
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01MH065151)
Article History
Received: 25 July 2018
Accepted: 13 December 2018
First Online: 31 January 2019
Competing Interests
: Dr. Weinand is a co-inventor of U.S. Provisional Patent 61/828,596, “Neurosurgical Genomics”, University of Arizona. Drs Sprissler, Hammer and Weinand are co-inventors of “Methods utilizing leukocyte RNA expression in prognostic evaluation of medical interventions for epilepsy”. US Patent Application Number 62/741,719. UA reference Number UA19-014. Filed October 5, 2018.